If you've been searching for information about PCOS recently, you may have noticed something: it's increasingly being referred to as PMOS. This isn't a typo or a regional variation. In 2026, a global consensus of medical and scientific organisations officially adopted a new name for the condition — and the change matters more than it might seem.
This guide explains what PMOS is, why the name changed, what it means for women living with it, and how you can genuinely support someone in your life who has it.
What is PMOS?
PMOS stands for Polyendocrine Metabolic Ovarian Syndrome. It's one of the most common hormonal conditions affecting people with ovaries, with the landmark 2026 Lancet consensus paper reporting that it affects 1 in 8 women worldwide — that's more than 170 million people.1
The condition involves a complex interaction of hormonal imbalances, metabolic factors, and effects on the ovaries. Despite the word "syndrome" in the name, PMOS is not a single, uniform condition — it presents differently from person to person, and two women with PMOS may have very different experiences of it.
Why did the name change from PCOS to PMOS?
The rename followed an unprecedented global consensus process involving 56 leading academic, clinical, and patient organisations, and drew on over 14,000 survey responses from patients and health professionals across multiple world regions.1 The process took over a decade.
The old name — Polycystic Ovary Syndrome — had two significant problems:
- Not everyone with the condition has cysts on their ovaries. The "cysts" seen on ultrasound are actually arrested follicles — calling them cysts was a misnomer from the start, and it led to significant diagnostic delays affecting up to 70% of those with the condition.2
- The name focused entirely on the ovaries, obscuring the fact that the condition involves the wider endocrine (hormonal) and metabolic systems — including insulin resistance, adrenal function, and more.
The new name — Polyendocrine Metabolic Ovarian Syndrome — is more accurate. "Polyendocrine" acknowledges the multiple hormonal systems involved. "Metabolic" captures the metabolic components (particularly insulin resistance, which is central to many cases). "Ovarian" keeps the connection to the ovaries without implying cysts are always present.
In plain terms: the condition didn't change. The understanding of it improved, and the name caught up. If someone you know was diagnosed with PCOS, they have PMOS — they're the same condition. Read the STAT News coverage ↗
What does PMOS actually feel like?
This is where it gets important for the people around someone with PMOS. Because it's a systemic condition — not just a reproductive one — its effects can touch many areas of life.
Common experiences for women with PMOS include:
- Irregular, unpredictable, or absent periods — which makes cycle awareness more difficult and uncertainty a regular part of life
- Fatigue that doesn't always correlate with how much sleep they've had — often related to insulin resistance and metabolic factors
- Mood changes and low mood, which research increasingly links to the hormonal and metabolic aspects of the condition rather than just the stress of having it
- Skin changes including acne — often hormonal in origin and frequently distressing
- Weight changes or difficulty managing weight, even with careful diet and exercise — not a willpower issue, a metabolic one
- Fertility challenges, which can carry significant emotional weight whether or not children are currently wanted
- Brain fog and difficulty concentrating, which is underreported but very real for many people with the condition
Important: this list represents what is common, not what every person with PMOS experiences. Some people have a single symptom. Some have many. Some manage well most of the time; others find it significantly affects daily life. Don't assume you know the shape of it for the person in your life — ask.
How cycles are affected
For many women with PMOS, cycles are irregular. This has practical implications: standard cycle awareness — including the kind Yori provides — works from a regular cycle length. When cycles are highly variable, predictions are less reliable.
Yori accounts for this. Its cycle length estimates are built from logged period data rather than a fixed assumption, and it flags early estimates as approximate. Over time, as more periods are logged, the picture becomes clearer — even if it remains more variable than a typical cycle.
The more important point is this: if she seems to be in a harder patch and the cycle picture doesn't fully explain it, that's normal for PMOS. Her body is doing something more complex than a standard 28-day cycle. Working with that uncertainty — rather than trying to predict through it — is the more honest approach.
How to genuinely support someone with PMOS
There's no script for this, because the condition is different for everyone. But a few principles hold up broadly:
- Believe her. PMOS is frequently dismissed, misdiagnosed, or minimised — including by medical professionals. If she says she's exhausted, or that her skin is affecting her confidence, or that she can't lose weight despite trying: believe her. The condition has a physiological basis, not a motivational one.
- Don't optimise. Listen. It can be tempting to research supplements, diets, or treatments and arrive with solutions. Sometimes that's welcome. Often what's needed first is just to be heard — not fixed.
- Understand the emotional weight of unpredictability. Not knowing when her period will arrive, or whether it will at all, is its own kind of stress. Being patient with uncertainty, rather than asking for timelines she can't give you, matters.
- Know that some days will be harder for reasons she can't fully explain. The brain fog, the fatigue, the mood — these aren't always traceable to a single cause. They don't require a reason to be real.
PMOS and Yori
Yori supports PMOS as one of its six dedicated conditions. When a profile is set up with PMOS, the AI insights and phase guidance adapt to reflect the irregular cycle patterns, the metabolic and energy-related symptoms, and the different kind of support that's often helpful during flares.
Yori updated its terminology to PMOS (with "formerly PCOS" shown alongside it) in line with the 2026 consensus — so if you're using the app and see the new term, that's intentional.
Supporting her starts with understanding
Yori helps you build awareness of her patterns over time, and get daily insights grounded in what you actually observe — not generic advice.
Download Yori on Android ↗Sources & further reading
- 1. Teede HJ, et al. Polyendocrine metabolic ovarian syndrome, the new name for polycystic ovary syndrome: a multistep global consensus process. The Lancet. Published May 12, 2026. doi:10.1016/S0140-6736(26)00717-8 ↗
- 2. Contemporary OB/GYN. Global consensus renames PCOS to polyendocrine metabolic ovarian syndrome (PMOS). 2026. Read article ↗
- 3. STAT News. PCOS is now called PMOS. The renaming process lasted a decade. May 2026. Read article ↗
- 4. AJMC. PCOS Renamed PMOS in Landmark Shift Reflecting Metabolic and Endocrine Features. 2026. Read article ↗